Although NSE has become a widely used laboratory assay of patients with SCLC [28], the diagnostic and prognostic sensitivity and specificity of NSE have been found to be lower than those of ProGRP, especially in early stages of SCLC [15, 17, 18, 29]. This evidence concerns the gene ENO2 and small cell lung carcinoma.